Poster 15
- Jun 20, 2023
- 1 min read
Lebrikizumab Dosed Every 8 Weeks as Maintenance Provides Long-Lasting Response in Patients with Moderate-to-Severe Atopic Dermatitis
Jonathan Silverberg, Vivian Laquer, Peter Lio, Kim Papp, Alan Irvine, Andrew Blauvelt, Hany Elmaraghy, Louise DeLuca-Carter, Heidi Crane, Gaia Gallo, Evangeline Pierce, Yuxin Ding7 Amy S. Paller


